Humana (HUM) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities
Net income	1.02B
Adjustments to reconcile net income to net cash provided by operating activities:
Net realized capital gains	-65M
Stock-based compensation	76M
Depreciation and amortization	289M
Provision (benefit) for deferred income taxes	54M
Changes in operating assets and liabilities, net of effect of businesses acquired:
Receivables	396M
Other assets	-419M
Benefits payable	73M
Other liabilities	127M
Unearned revenues	2.99B
Other, net	117M
Net cash provided by operating activities	4.71B
Cash flows from investing activities
Acquisitions, net of cash acquired	-7M
Purchases of property and equipment	-395M
Purchases of investment securities	-4.53B
Maturities of investment securities	1.08B
Proceeds from sales of investment securities	3.32B
Change in securities lending collateral
Net cash used in investing activities	-534M
Cash flows from financing activities
Receipts from CMS contract deposits
Withdrawals from CMS contract deposits
Change in securities lending payable
Change in book overdraft	-118M
Common stock repurchases	-75M
Excess tax benefit from stock-based compensation	0
Proceeds from stock option exercises and other	0
Net cash used in financing activities	23M
(Decrease) increase in cash and cash equivalents	4.2B
Cash and cash equivalents at beginning of period	2.57B
Cash and cash equivalents at end of period	6.77B
Supplemental cash flow disclosures:
Interest payments	102M
Income tax payments, net	851M

Entities mentioned with hum